Biodesix (BDSX) vs TriSalus Life Sciences (TLSI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Biodesix (BDSX) has outperformed TriSalus Life Sciences (TLSI) over the past year, gaining 230.7% versus a loss of 11.1%. Over five years, TLSI leads with a -57.1% price change compared with -82.9% for BDSX. Biodesix is the larger company by market cap ($270.4 million vs $254.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BDSX | TLSI |
|---|---|---|
| Share price | $25.63 | $4.13 |
| Market cap | $270.43M | $254.30M |
| 1-day change | -2.99% | -2.82% |
| YTD return | +276.91% | -39.11% |
| 1-year return | +230.71% | -11.09% |
| 5-year return | -82.91% | -57.07% |
| EPS (TTM) | $-3.10 | $-1.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $31.97 | $7.95 |
| 52-week low | $5.26 | $2.20 |
| Distance from 52-week high | -19.83% | -48.05% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +45.65% | +151.82% |
| Average volume | 100.74K | 275.38K |
| Shares outstanding | 10.55M | 61.57M |
| Employees | 334 | 102 |
| Sector | Health Care | Healthcare |
| Industry | Medical Specialities | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BDSX has outperformed TLSI by 241.8 percentage points over the past year.
- The two companies sit in different sectors: Biodesix in Health Care and TriSalus Life Sciences in Healthcare.
About Biodesix
BDSX stock →Biodesix, Inc. operates as a diagnostic solutions company.
Health Care · Medical Specialities · 334 employees
About TriSalus Life Sciences
TLSI stock →TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States.
Healthcare · Medical Devices · 102 employees
BDSX vs TLSI FAQ
Which is bigger, Biodesix or TriSalus Life Sciences?
Biodesix (BDSX) is larger, with a market capitalization of $270.43M compared with $254.30M for TriSalus Life Sciences (TLSI).
Which stock has performed better over the past year, BDSX or TLSI?
BDSX returned +230.71% over the past 12 months, compared with -11.09% for TLSI (price return, excluding dividends). Past performance does not predict future results.
Are Biodesix and TriSalus Life Sciences in the same industry?
No. Biodesix is in the Health Care sector, while TriSalus Life Sciences is in Healthcare.